|
| Read more ›› |
|
By: GlobenewsWire - 10 Nov 2020
|
|
Related companies:
DBV Technologies S.A. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
Related companies:
Inventiva Pharma |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
Related companies:
EDAP TMS S.A. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
Related companies:
EssilorLuxottica |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
Related companies:
OSE Immunotherapeutics SA |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Nov 2020
|
|
Related companies:
DBV Technologies S.A. |
|
|
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
|
By: PR Newswire Association LLC. - 09 Nov 2020
|
|
|
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
|
By: PR Newswire Association LLC. - 08 Nov 2020
|
|
|
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
|
By: PR Newswire Association LLC. - 08 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Nov 2020
|
|
Related companies:
Virbac |
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Nov 2020
|
|
Related companies:
Pharmagest Interactive SA |
|
|
BRUSSELS, Nov. 5, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its TNF inhibitor, CIMZIA(® )(certolizumab pegol), and investigational IL-17A and IL-17F inhibitor, bimekizumab. Data are being presented at the American College of Rheumatology... Read more ›› |
|
By: PR Newswire Association LLC. - 06 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
Related companies:
Inventiva Pharma |
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
Related companies:
Innate Pharma S.A. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
Related companies:
OSE Immunotherapeutics SA |
|
|
ABL Europe uses viral vector expertise to collaborate with University Clinic of Tuebingen and Prime Vector Technologies for development and manufacture of its 2(nd) generation SARS-CoV-2 Vaccine Candidate Read more ›› |
|
By: PR Newswire Association LLC. - 05 Nov 2020
|
|
Related companies:
ABL Europe SAS |
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
|
|
|
|
Biotechgate Global Database ›
